Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$20.66 - $28.98 $68,198 - $95,662
-3,301 Reduced 8.1%
37,433 $791,000
Q3 2022

Nov 22, 2022

SELL
$18.51 - $24.79 $319,482 - $427,875
-17,260 Reduced 29.76%
40,734 $979,000
Q1 2022

Jun 07, 2022

BUY
$14.84 - $22.15 $109,578 - $163,555
7,384 Added 14.59%
57,994 $1.01 Million
Q3 2021

Nov 10, 2021

BUY
$13.87 - $19.8 $96,979 - $138,441
6,992 Added 16.03%
50,610 $967,000
Q1 2021

May 19, 2021

BUY
$19.28 - $24.59 $456,261 - $581,922
23,665 Added 118.6%
43,618 $975,000
Q4 2020

Mar 08, 2021

BUY
$15.1 - $26.44 $301,290 - $527,557
19,953 New
19,953 $444,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $946M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.